COGNITIVE FUNCTION IN CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER RECEIVING LISDEXAMFETAMINE DIMESYLATE IN A 2-YEAR SAFETY STUDY

被引：0
|
作者：
Coghill, D. [1 ,2 ,3 ]
Banaschewski, T. [4 ]
Bliss, C. [5 ]
Robertson, B. [5 ]
Zuddas, A. [6 ]
机构：
[1] Univ Dundee, Div Neurosci, Dundee, Scotland
[2] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Paediat, Melbourne, Vic, Australia
[3] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Psychiat, Melbourne, Vic, Australia
[4] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Child & Adolescent Psychiat & Psychotherapy, Mannheim, Germany
[5] Shire, Lexington, MA USA
[6] Univ Cagliari, Dept Biomed Sci, Child & Adolescent Psychiat Unit, Sect Neurosci & Clin Pharmacol, Cagliari, Italy
来源：
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY | 2017年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：106 / 107
页数：2
相关论文
共 50 条
  • [41] Effectiveness, Safety, and Tolerability of Lisdexamfetamine Dimesylate in Children With Attention-Deficit/Hyperactivity Disorder: An Open-Label, Dose-Optimization Study
    Findling, Robert L.
    Ginsberg, Lawrence D.
    Jain, Rakesh
    Gao, Joseph
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2009, 19 (06) : 649 - 662
  • [42] Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial
    David R. Coghill
    Tobias Banaschewski
    Michel Lecendreux
    Alessandro Zuddas
    Ralf W. Dittmann
    Isabel Hernández Otero
    Richard Civil
    Ralph Bloomfield
    Liza A. Squires
    European Child & Adolescent Psychiatry, 2014, 23 : 61 - 68
  • [43] Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial
    Coghill, David R.
    Banaschewski, Tobias
    Lecendreux, Michel
    Zuddas, Alessandro
    Dittmann, Ralf W.
    Otero, Isabel Hernandez
    Civil, Richard
    Bloomfield, Ralph
    Squires, Liza A.
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2014, 23 (02) : 61 - 68
  • [44] An update on lisdexamfetamine dimesylate for the treatment of attention deficit hyperactivity disorder
    Wigal, Sharon B.
    Raja, Pooja
    Shukla, Ankita
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (01) : 137 - 145
  • [45] Long-term effectiveness and safety of lisdexamfetamine dimesylate in children aged 6-12 with attention-deficit/hyperactivity disorder
    McGough, J.
    Childress, A.
    Krishnan, S.
    Findling, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S559 - S559
  • [46] Long-term safety and tolerability of lisdexamfetamine dimesylate in children aged 6 to 12 years with attention-deficit/hyperactivity disorder
    Findling, Robert L.
    Lopez, Frank A.
    Childress, Ann C.
    Krishnan, Suma
    McGough, James
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2007, 17 (06) : 875 - 875
  • [47] The Efficacy and Safety Profile of Lisdexamfetamine Dimesylate, a Prodrug of d-Amphetamine, for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adults
    Najib, Jadwiga
    CLINICAL THERAPEUTICS, 2009, 31 (01) : 142 - 176
  • [48] Phase II/III Study of Lisdexamfetamine Dimesylate in Japanese Pediatric Patients with Attention-Deficit/Hyperactivity Disorder
    Ichikawa, Hironobu
    Miyajima, Tasuku
    Yamashita, Yushiro
    Fujiwara, Masakazu
    Fukushi, Akimasa
    Saito, Kazuhiko
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2020, 30 (01) : 21 - 31
  • [49] Lisdexamfetamine for Treatment of Attention-Deficit/Hyperactivity Disorder
    Cowles, Brian J.
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (04) : 669 - 676
  • [50] Efficacy of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder previously treated with methylphenidate: A post hoc analysis
    Jain R.
    Babcock T.
    Burtea T.
    Dirks B.
    Adeyi B.
    Scheckner B.
    Lasser R.
    Child and Adolescent Psychiatry and Mental Health, 5 (1)
12345